Reference:
Ahmad A, Yang W, Chen G, Shafiq M, Javed S, Ali Zaidi SS, et al. (2019)
Analysis of gut microbiota of obese individuals with type 2 diabetes and
healthy individuals. PLoS One. 14 (12): e0226372.
doi:10.1371/journal.pone.0226372.
Al-Rubeaan K. (2015) National surveillance for type 1, type 2 diabetes
and prediabetes among children and adolescents: a population-based study
(SAUDI-DM). J Epidemiol Community Health. 69 (11): 1045-1051.
doi:10.1136/jech-2015-205710.
Beale EG. (2013) Insulin signaling and insulin resistance. J Investig
Med. 61 (1): 11-14. doi:10.2310/JIM.0b013e3182746f95.
Becker J, Gießelmann G, Hoffmann SL, Wittmann C. (2018) Corynebacterium
glutamicum for Sustainable Bioproduction: From Metabolic Physiology to
Systems Metabolic Engineering. Adv Biochem Eng Biotechnol. 162 217-263.
doi:10.1007/10_2016_21.
Bergeron V, Ghislain J, Vivot K, Tamarina N, Philipson LH, Fielitz J, et
al. (2018) Deletion of Protein Kinase D1 in Pancreatic β-Cells Impairs
Insulin Secretion in High-Fat Diet-Fed Mice. Diabetes. 67 (1): 71-77.
doi:10.2337/db17-0982.
Bhatti AA, Haq S, Bhat RA. (2017) Actinomycetes benefaction role in soil
and plant health. Microb Pathog. 111 458-467.
doi:10.1016/j.micpath.2017.09.036.
Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al.
(2007) Metabolic endotoxemia initiates obesity and insulin resistance.
Diabetes. 56 (7): 1761-1772. doi:10.2337/db06-1491.
Edgerton DS, Lautz M, Scott M, Everett CA, Stettler KM, Neal DW, et al.
(2006) Insulin’s direct effects on the liver dominate the control of
hepatic glucose production. J Clin Invest. 116 (2): 521-527.
doi:10.1172/JCI27073.
Federico A, Dallio M, R DIS, Giorgio V, Miele L. (2017) Gut microbiota,
obesity and metabolic disorders. Minerva Gastroenterol Dietol. 63 (4):
337-344. doi:10.23736/S1121-421X.17.02376-5.
Fugmann M, Breier M, Rottenkolber M, Banning F, Ferrari U, Sacco V, et
al. (2015) The stool microbiota of insulin resistant women with recent
gestational diabetes, a high risk group for type 2 diabetes. Sci Rep. 5
13212. doi:10.1038/srep13212.
Jayachandran M, Xiao J, Xu B. (2017) A Critical Review on Health
Promoting Benefits of Edible Mushrooms through Gut Microbiota. Int J Mol
Sci. 18 (9): 1934. doi:10.3390/ijms18091934.
Jiang Y, Liu J, Zhou Z, Liu K, Liu C. (2018) Diosmetin Attenuates Akt
Signaling Pathway by Modulating Nuclear Factor
Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κB)/Inducible Nitric
Oxide Synthase (iNOS) in Streptozotocin (STZ)-Induced Diabetic
Nephropathy Mice. Med Sci Monit. 24 7007-7014. doi:10.12659/MSM.910764.
Kattan W, Wan TTH. (2018) Factors Influencing Variations in
Hospitalization for Diabetes with Hypoglycemia. J Clin Med. 7 (10): 367.
doi:10.3390/jcm7100367.
Lange K, Buerger M, Stallmach A, Bruns T. (2016) Effects of Antibiotics
on Gut Microbiota. Dig Dis. 34 (3): 260-268. doi:10.1159/000443360.
Lee JY, Na YA, Kim E, Lee HS, Kim P. (2016) The Actinobacterium
Corynebacterium glutamicum, an Industrial Workhorse. J Microbiol
Biotechnol. 26 (5): 807-822. doi:10.4014/jmb.1601.01053.
Muñoz-Garach A, Diaz-Perdigones C, Tinahones FJ. (2016) Gut microbiota
and type 2 diabetes mellitus. Endocrinol Nutr. 63 (10): 560-568.
doi:10.1016/j.endonu.2016.07.008.
Niswender KD. (2011) Basal insulin: physiology, pharmacology, and
clinical implications. Postgrad Med. 123 (4): 17-26.
doi:10.3810/pgm.2011.07.2300.
Petersen MC, Vatner DF, Shulman GI. (2017) Regulation of hepatic glucose
metabolism in health and disease. Nat Rev Endocrinol. 13 (10): 572-587.
doi:10.1038/nrendo.2017.80.
Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. (2012) A
metagenome-wide association study of gut microbiota in type 2 diabetes.
Nature. 490 (7418): 55-60. doi:10.1038/nature11450.
Sabatino A, Regolisti G, Cosola C, Gesualdo L, Fiaccadori E. (2017)
Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.
Curr Diab Rep. 17 (3): 16. doi:10.1007/s11892-017-0841-z.
Saito S, Oishi S, Shudo A, Sugiura Y, Yasunaga K. (2019) Glucose
Response during the Night Is Suppressed by Wheat Albumin in Healthy
Participants: A Randomized Controlled Trial. Nutrients. 11 (1): 187.
doi:10.3390/nu11010187.
Seibold G, Dempf S, Schreiner J, Eikmanns BJ. (2007) Glycogen formation
in Corynebacterium glutamicum and role of ADP-glucose pyrophosphorylase.
Microbiology (Reading). 153 (Pt 4): 1275-1285.
doi:10.1099/mic.0.2006/003368-0.
Spencer MD, Hamp TJ, Reid RW, Fischer LM, Zeisel SH, Fodor AA. (2011)
Association between composition of the human gastrointestinal microbiome
and development of fatty liver with choline deficiency.
Gastroenterology. 140 (3): 976-986. doi:10.1053/j.gastro.2010.11.049.
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI.
(2006) An obesity-associated gut microbiome with increased capacity for
energy harvest. Nature. 444 (7122): 1027-1031. doi:10.1038/nature05414.
Tzeng TF, Lu HJ, Liou SS, Chang CJ, Liu IM. (2012) Emodin, a Naturally
Occurring Anthraquinone Derivative, Ameliorates Dyslipidemia by
Activating AMP-Activated Protein Kinase in High-Fat-Diet-Fed Rats. Evid
Based Complement Alternat Med. 2012 781812. doi:10.1155/2012/781812.
van Bommel EJM, Herrema H, Davids M, Kramer MHH, Nieuwdorp M, van Raalte
DH. (2020) Effects of 12-week treatment with dapagliflozin and
gliclazide on faecal microbiome: Results of a double-blind randomized
trial in patients with type 2 diabetes. Diabetes Metab. 46 (2): 164-168.
doi:10.1016/j.diabet.2019.11.005.
Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S,
Srinivasan S, et al. (2010) Metabolic syndrome and altered gut
microbiota in mice lacking Toll-like receptor 5. Science. 328 (5975):
228-231. doi:10.1126/science.1179721.
Wei M, Huang F, Zhao L, Zhang Y, Yang W, Wang S, et al. (2020) A
dysregulated bile acid-gut microbiota axis contributes to obesity
susceptibility. EBioMedicine. 55 102766.
doi:10.1016/j.ebiom.2020.102766.
Wu H, Esteve E, Tremaroli V, Khan MT, Caesar R, Mannerås-Holm L, et al.
(2017) Metformin alters the gut microbiome of individuals with
treatment-naive type 2 diabetes, contributing to the therapeutic effects
of the drug. Nat Med. 23 (7): 850-858. doi:10.1038/nm.4345.
Xia Y, Su Y, Wang Q, Yang C, Tang B, Zhang Y, et al. (2019) Preparation,
characterization, and pharmacodynamics of insulin-loaded fumaryl
diketopiperazine microparticle dry powder inhalation. Drug Deliv. 26
(1): 650-660. doi:10.1080/10717544.2019.1631408.
Yang Y, Gong XB, Huang LG, Wang ZX, Wan RZ, Zhang P, et al. (2017)
Diosmetin exerts anti-oxidative, anti-inflammatory and anti-apoptotic
effects to protect against endotoxin-induced acute hepatic failure in
mice. Oncotarget. 8 (19): 30723-30733. doi:10.18632/oncotarget.15413.
Zheng J, Yuan X, Cheng G, Jiao S, Feng C, Zhao X, et al. (2018) Chitosan
oligosaccharides improve the disturbance in glucose metabolism and
reverse the dysbiosis of gut microbiota in diabetic mice. Carbohydr
Polym. 190 77-86. doi:10.1016/j.carbpol.2018.02.058.